Fintepla (fenfluramine) — Highmark
Lennox-Gastaut syndrome
Initial criteria
- age ≥ 2 years
- diagnosis of Lennox-Gastaut syndrome
- therapeutic failure, contraindication, or intolerance to two of the following: valproic acid or divalproex sodium, lamotrigine, topiramate, clobazam
Reauthorization criteria
- prescriber attests that the member has experienced a reduction in seizure frequency from baseline
Approval duration
12 months